The impact of a school health programme on the prevalence and morbidity of urinary schistosomiasis in Mwera Division, Pangani District, Tanzania

被引:42
作者
Magnussen, P
Ndawi, B
Sheshe, AK
Byskov, J
Mbwana, K
Christensen, NA
机构
[1] Danish Bilharziasis Lab, DK-2920 Charlottenlund, Denmark
[2] Vector Control Training Ctr, Tanga, Tanzania
[3] Sch Environm Hlth, Tanga, Tanzania
关键词
schistosomiasis; Schistosoma haematobium; disease control; school programme; selective chemotherapy; praziquantel; morbidity; Tanzania;
D O I
10.1016/S0035-9203(01)90333-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The prevalence of urinary schistosomiasis among schoolchildren in Pangani District (Tanzania) was assessed rapidly by a questionnaire approach. Based on the results, a strategy of selective treatment with praziquantel was adopted. Eleven primary schools in Mwera Division, Pangani District, with about 2500 schoolchildren were included in a control programme for urinary schistosomiasis. Macru- and microscopic haematuria diagnosed visually and with urine reagent strips was used as an indirect indicator of Schistosoma haematobium infection. Intensity of infection among children was monitored in class 5 (median age 14 years, range 11-17) by urine filtration techniques. Treatment was administered as 40 mg/kg praziquantel in a single dose at the beginning of the school year. The programme was implemented by schoolteachers and coordinated by the District Health Management Team in collaboration with the District Education Office. Teachers were responsible for carrying out all programme activities. Community participation was through collaboration with Teachers-Parents Associations and Village Health Committees. Coverage at yearly (1995-99) examination varied from 67.7% to 80.3%. Prevalence of haematuria decreased from 51.2% (range 22.2-89.5%) at baseline to 23.4% (range 58-56.7%) in 1999, a reduction of 54.3%. Macrohaematuria was 21.2% at baseline and 7.2% in 1999, a reduction of 66.0%. Prevalence of infection in class 5 was reduced by 71.4% and geometric mean intensity of positives reduced from 71 eggs/10 mL (95% confidence interval [CI] 52.5-97.7) to 28 eggs/10 mL (95% CI 25.7-55.0), a reduction of 60.6%. Teachers were highly committed, and secured community participation and a smooth implementation of the programme. The community accepted the introduction of a cost-recovery system, whereby parents pay for the treatment of children with episodes of visible haematuria during the school year. Communities also participated in the improvement of sanitary installations at the schools.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 17 条
[1]  
[Anonymous], 1993, World Development Report 1993: Investing in Healthl
[2]  
Ansell J, 1999, B WORLD HEALTH ORGAN, V77, P477
[3]  
Bundy D, 1997, T ROY SOC TROP MED H, V91, P1, DOI 10.1016/S0035-9203(97)90370-9
[4]   Schools for health: Focus on health, education and the school-age child [J].
Bundy, DAP ;
Guyatt, HL .
PARASITOLOGY TODAY, 1996, 12 (08) :1-16
[5]   THE EVALUATION OF POTENTIAL GLOBAL MORBIDITY ATTRIBUTABLE TO INTESTINAL NEMATODE INFECTIONS [J].
CHAN, MS ;
MEDLEY, GF ;
JAMISON, D ;
BUNDY, DAP .
PARASITOLOGY, 1994, 109 :373-387
[6]  
Clyde David F, 1967, MALARIA TANZANIA
[7]   The performance of school-based questionnaires of reported blood in urine in diagnosing Schistosoma haematobium infection:: patterns by age and sex [J].
Guyatt, H ;
Brooker, S ;
Lwambo, NJS ;
Siza, JE ;
Bundy, DAP .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1999, 4 (11) :751-757
[8]   USING QUESTIONNAIRES THROUGH AN EXISTING ADMINISTRATIVE SYSTEM - A NEW APPROACH TO HEALTH INTERVIEW SURVEYS [J].
LENGELER, C ;
SALADIAKANDA, DM ;
TANNER, M .
HEALTH POLICY AND PLANNING, 1992, 7 (01) :10-21
[9]   A school-based approach to the control of urinary schistosomiasis and intestinal helminth infections in children in Matuga, Kenya: impact of a two-year chemotherapy programme on prevalence and intensity of infections [J].
Magnussen, P ;
Muchiri, E ;
Mungai, P ;
Ndzovu, M ;
Ouma, J ;
Tosha, S .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (09) :825-831
[10]  
*PARTN CHILD DEV, 1997, COST AN SCH BAS DRUG